Trials / Completed
CompletedNCT03233334
Purpose Project: Reclaiming Life Purpose After Breast Cancer (Feasibility Study)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Allina Health System · Academic / Other
- Sex
- Female
- Age
- 25 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The Purpose Project intervention is an 8-session progressive structure that was developed based on theoretical and scientific evidence from psychology and occupational therapy. The goal of the intervention is to provide participants with information, tools, and support that help them move towards reclaiming a sense of self-grounded purpose in daily life. The study will use a convenience sample of women with breast cancer to evaluate the feasibility of the Purpose Project intervention in terms of demand/acceptability, implementation, and limited-efficacy testing. Findings will be used to inform a later study to evaluate the efficacy of the Purpose Project intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Purpose Project | The purpose project intervention 8-session group intervention that integrates education, support, self-reflection, and action-expectation to help people reaffirm or reconstruct self-grounded purpose after significant life events/transitions. The 8 sessions extend over 2-3 months, with 7 weekly sessions and the final session 1 month after Session 7. The intervention is structured around the 6 dimensions of flourishing (autonomy, self-acceptance, personal growth, relationships, purpose in life, external mastery), the goal of which is to help people enact behaviors that move them forward in reframing a sense of self and reaffirming or reconstructing a sense of purpose in life that helps them flourish. |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-08-01
- Completion
- 2019-01-31
- First posted
- 2017-07-28
- Last updated
- 2019-07-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03233334. Inclusion in this directory is not an endorsement.